Abstract 12558: 3-year Outcomes In Stable Coronary Artery Disease Patients With Diabetes Based On A Novel Index: Computational Pressure-flow Dynamics Derived Fractional Flow Reserve
Kwan Yu LI,Lok Yee Jane Lam,Ka Lam Calvin Leung,Qingwen Ren,Mei Zhen Wu,Yi Kei Stephanie Tse,Si-Yeung Yu,Hang Long Li,Pui Fai Wong,Shuk Yin Yu,Yundi Feng,Yunlong Huo,Kai Hang Yiu,Kwan Yu LILok Yee Jane LamKa Lam Calvin LeungQingwen RenMei Zhen WuYi Kei Stephanie TseSi-Yeung YuHang Long LiPui Fai WongShuk Yin YuYundi FengYunlong HuoKai Hang YiuDept of Medicine,The Univ of Hong Kong,Hong KongQueen Mary Hosp,Hong KongHong KongThe Univ of Hong Kong,Hong Kong
DOI: https://doi.org/10.1161/circ.144.suppl_1.12558
IF: 37.8
2021-11-10
Circulation
Abstract:Circulation, Volume 144, Issue Suppl_1, Page A12558-A12558, November 16, 2021. Introduction:Computational pressure-flow dynamics derived fractional flow reserve (caFFR) has emerged for non-invasive assessment of fractional flow reserve (FFR) in patients with stable coronary artery disease (CAD), without the need for hyperaemic induction and guidewire placement in conventional FFR. The clinical value of caFFR in diabetic patients, who are at risk of microvascular dysfunction, has not been validated. The aim of the study is to evaluate the use of caFFR in diabetic patients with stable CAD.Methods:A total of 212 stable CAD patients with diabetes (mean age=67.6±10.6, 66.5% male) were included. Patients were said to be adherent to caFFR if all ischemic vessels, defined by caFFR≤0.8 were treated with PCI and all nonischemic vessels, defined by caFFR>0.8 were not. Otherwise, they were considered to be non-adherent to caFFR. The primary endpoint was 3-year major adverse cardiac events (MACE), defined as a composite of cardiovascular mortality, non-fatal myocardial infarction (MI), stroke and unplanned revascularization.Results:Among the 212 patients, PCI was performed in 62.3% of them. A total of 26 composite events occurred, including 5 cardiovascular mortality, 5 non-fatal MI, 2 strokes and 14 unplanned revascularization. The incidence rate of MACE was significantly lower in adherent patients than in non-adherent patients (5.4% vs 15.8%; P=0.01). After multivariate adjustment, adherent patients had a significantly lower risk of MACE than non-adherent patients (adjusted hazard ratio [HR], 0.33; 95% confidence interval [Cl], 0.13-0.83; P=0.02).Conclusions:In stable CAD patients with diabetes, caFFR-guided revascularization significantly reduces the risk of MACE in 3 years. The findings support the potential use of caFFR in treatment guidance of diabetic patients.
cardiac & cardiovascular systems,peripheral vascular disease